AIGH Capital Management’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-300,766
| Closed | -$499K | – | 39 |
|
|
2024
Q2 | $499K | Sell |
300,766
-1,596,507
| -84% | -$2.65M | 0.16% | 32 |
|
|
2024
Q1 | $3.45M | Sell |
1,897,273
-141,580
| -7% | -$258K | 1.04% | 26 |
|
|
2023
Q4 | $3.77M | Hold |
2,038,853
| – | – | 1.49% | 26 |
|
|
2023
Q3 | $2.94M | Hold |
2,038,853
| – | – | 1.39% | 20 |
|
|
2023
Q2 | $3.73M | Buy |
2,038,853
+1,000
| +0% | +$1.83K | 1.52% | 19 |
|
|
2023
Q1 | $4.03M | Hold |
2,037,853
| – | – | 1.49% | 20 |
|
|
2022
Q4 | $4.28M | Buy |
2,037,853
+1,239,518
| +155% | +$2.6M | 1.41% | 21 |
|
|
2022
Q3 | $1.52M | Sell |
798,335
-112,455
| -12% | -$214K | 0.47% | 31 |
|
|
2022
Q2 | $2.38M | Buy |
+910,790
| New | +$2.38M | 0.63% | 24 |
|
|
2022
Q1 | – | Sell |
-25,496
| Closed | -$161K | – | 40 |
|
|
2021
Q4 | $161K | Buy |
+25,496
| New | +$161K | 0.05% | 45 |
|